Next Article in Journal
The Effect of Secretory Factors of Adipose-Derived Stem Cells on Human Keratinocytes
Previous Article in Journal
Targeting Protective Autophagy Exacerbates UV-Triggered Apoptotic Cell Death
Int. J. Mol. Sci. 2012, 13(1), 1225-1238; doi:10.3390/ijms13011225
Review

Disruption of Axonal Transport in Motor Neuron Diseases

1
,
1,* , 1
,
1,2
,
1
 and
1,2,*
Received: 2 November 2011 / Revised: 11 January 2012 / Accepted: 16 January 2012 / Published: 23 January 2012
View Full-Text   |   Download PDF [310 KB, uploaded 19 June 2014]   |   Browse Figures

Abstract

Motor neurons typically have very long axons, and fine-tuning axonal transport is crucial for their survival. The obstruction of axonal transport is gaining attention as a cause of neuronal dysfunction in a variety of neurodegenerative motor neuron diseases. Depletions in dynein and dynactin-1, motor molecules regulating axonal trafficking, disrupt axonal transport in flies, and mutations in their genes cause motor neuron degeneration in humans and rodents. Axonal transport defects are among the early molecular events leading to neurodegeneration in mouse models of amyotrophic lateral sclerosis (ALS). Gene expression profiles indicate that dynactin-1 mRNA is downregulated in degenerating spinal motor neurons of autopsied patients with sporadic ALS. Dynactin-1 mRNA is also reduced in the affected neurons of a mouse model of spinal and bulbar muscular atrophy, a motor neuron disease caused by triplet CAG repeat expansion in the gene encoding the androgen receptor. Pathogenic androgen receptor proteins also inhibit kinesin-1 microtubule-binding activity and disrupt anterograde axonal transport by activating c-Jun N-terminal kinase. Disruption of axonal transport also underlies the pathogenesis of spinal muscular atrophy and hereditary spastic paraplegias. These observations suggest that the impairment of axonal transport is a key event in the pathological processes of motor neuron degeneration and an important target of therapy development for motor neuron diseases.
Keywords: axonal transport; dynactin-1; dynein; kinesin; neurofilament; motor neuron; amyotrophic lateral sclerosis; spinal and bulbar muscular atrophy; spinal muscular atrophy; hereditary spastic paraplegia axonal transport; dynactin-1; dynein; kinesin; neurofilament; motor neuron; amyotrophic lateral sclerosis; spinal and bulbar muscular atrophy; spinal muscular atrophy; hereditary spastic paraplegia
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Ikenaka, K.; Katsuno, M.; Kawai, K.; Ishigaki, S.; Tanaka, F.; Sobue, G. Disruption of Axonal Transport in Motor Neuron Diseases. Int. J. Mol. Sci. 2012, 13, 1225-1238.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert